| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |